Has Steven Bolling, MD received payments from drug or device companies?

Yes. Drug and device makers reported $41,674,286 in general payments to Steven Bolling, MD across 356 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Bolling, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Bolling, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Bolling, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Ann Arbor, MINPI 1518059989

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $41,286,410 of the $41,674,286 with a category attached, or 99.1%. Boston Scientific accounts for 99.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $37,351,438 and has fallen 100.0% since, to $5,144 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$41,674,286in general payments, 2019–2025

Across 356 payments — averaging $117,063 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$41.4M
W. L. Gore & Associates, Inc.$238K
Medtronic$31K
Edwards Lifesciences$26K
Abbott$20K
Atricure, Inc.$1K
plus $2K from 5 others

$728,517in research payments, 2019–2025

Across 150 payments — averaging $4856.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$429K
Edwards Lifesciences$160K
Abbott$139K

What the payments were for

Consulting fees$268,4811%
Speaking & faculty fees$41,5000%
Grants$1,5000%
Travel & lodging$33,9630%
Food & beverage$17,2700%
Ownership interest$41,286,41099%
Other$25,1620%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	44	$41,356,031
W. L. Gore & Associates, Inc.	61	$237,947
Medtronic(2 entities)	88	$30,527
Edwards Lifesciences	83	$26,195
Abbott	59	$19,713
Atricure, Inc.	10	$1,435
AbbVie	4	$1,079
Philips North America LLC	4	$904
Biosense Webster, Inc.	1	$334
GE HealthCare	1	$90
Baxter Healthcare	1	$31

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,674,286 in reported general payments places this provider in the 95th percentile of 182 thoracic surgery (cardiothoracic vascular surgery) providers in Michigan.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Michigan →

Medicare billing

Part B allowed, 2024

$138,898

Medicare patients

Services billed

157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	20	$23,042
Spironolactone-HctzSpironolact/Hydrochlorothiazid	44	$2,456
Metoprolol Succinate	64	$1,084
Potassium Chloride	35	$1,058
Warfarin Sodium	27	$715
Amiodarone Hcl	18	$395
Furosemide	38	$181
Omeprazole	20	$171
Metoprolol Tartrate	31	$142
Spironolactone	12	$62
Amoxicillin	26	$21

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Ann Arbor

Gorav AilawadiAnn Arbor$434K
Shinichi FukuharaAnn Arbor$236K
Bo YangAnn Arbor$180K
Matthew RomanoAnn Arbor$177K
Chigozirim EkekeAnn Arbor$92K
Himanshu PatelAnn Arbor$58K
Rishindra ReddyAnn Arbor$58K
Barbara HamiltonAnn Arbor$34K
Kenneth HasslerAnn Arbor$31K
Tessa WattAnn Arbor$22K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →